Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.86
-0.26 (-1.12%)
At close: Jul 24, 2026, 4:00 PM EDT
22.95
+0.09 (0.39%)
Pre-market: Jul 27, 2026, 7:01 AM EDT
Zymeworks Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 244.28 | 41.16 | 66.1 | 157.56 | 400.91 | 201.87 |
Short-Term Investments | 120.45 | 187.64 | 159.67 | 216.77 | 91.32 | 50.74 |
Cash & Short-Term Investments | 364.73 | 228.8 | 225.78 | 374.33 | 492.23 | 252.61 |
Cash Growth | 37.48% | 1.34% | -39.68% | -23.95% | 94.86% | -40.75% |
Accounts Receivable | 4.67 | 4.64 | 55.82 | 19.48 | 33.4 | 15.61 |
Other Current Assets | 16.28 | 15.33 | 18.86 | 19.12 | 19.07 | 20 |
Total Current Assets | 385.68 | 248.77 | 300.45 | 412.93 | 544.71 | 288.22 |
Net Property, Plant & Equipment | 28.87 | 31.23 | 34.32 | 37.54 | 47.65 | 49.77 |
Other Intangible Assets | 1.17 | 1.35 | 4.58 | 25.28 | 26.38 | 21.47 |
Goodwill | 12.02 | 12.02 | 12.02 | 12.02 | 12.02 | 12.02 |
Long-Term Investments | 39.12 | 41.79 | 98.43 | 81.93 | 0.89 | 0.89 |
Other Long-Term Assets | 11.36 | 11.38 | 13.3 | 11.18 | 17.08 | 16.77 |
Total Assets | 478.22 | 346.53 | 463.09 | 580.88 | 648.73 | 389.13 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 30.23 | 36.35 | 59.84 | 45.99 | 87.47 | 62.79 |
Current Portion of Leases | 3.28 | 3.47 | 2.74 | 4.26 | 3.32 | 1.31 |
Unearned Revenue | 2.08 | 2.42 | 25.59 | 3.7 | 2.35 | - |
Other Current Liabilities | 0.07 | 0.08 | 0.13 | 1.81 | 2.48 | 7.75 |
Total Current Liabilities | 35.65 | 42.32 | 88.29 | 55.76 | 95.63 | 71.85 |
Long-Term Leases | 13.76 | 14.8 | 15.74 | 22.37 | 24.67 | 30.92 |
Other Long-Term Liabilities | 265.21 | 20.91 | 20.29 | 37.94 | 35.48 | 37.26 |
Total Long-Term Liabilities | 278.98 | 35.71 | 36.03 | 60.31 | 60.14 | 68.19 |
Total Liabilities | 314.63 | 78.03 | 124.32 | 116.07 | 155.77 | 140.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,136 | 1,113 | 1,024 | 1,007 | 906.76 | 741.15 |
Additional Paid-in Capital | 107.53 | 114.63 | 152.25 | 142.27 | 151.61 | 197.71 |
Accumulated Other Comprehensive Income | -6.57 | -6.08 | -6.95 | -6.6 | -6.66 | -6.66 |
Retained Earnings | -1,074 | -953.16 | -830.34 | -677.44 | -558.76 | -683.1 |
Shareholders' Equity | 163.59 | 268.5 | 338.77 | 464.81 | 492.96 | 249.09 |
Total Liabilities & Equity | 478.22 | 346.53 | 463.09 | 580.88 | 648.73 | 389.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.04 | 18.27 | 18.48 | 26.63 | 27.99 | 32.23 |
Net Cash (Debt) | 347.69 | 210.53 | 207.3 | 347.7 | 464.24 | 220.38 |
Net Cash Growth | 40.85% | 1.56% | -40.38% | -25.11% | 110.66% | -47.26% |
Net Cash Per Share | 4.59 | 2.79 | 2.73 | 5.05 | 7.12 | 4.23 |
Book Value | 163.59 | 268.5 | 338.77 | 464.81 | 492.96 | 249.09 |
Book Value Per Share | 2.16 | 3.56 | 4.46 | 6.75 | 7.55 | 4.78 |
Tangible Book Value | 150.4 | 255.14 | 322.18 | 427.51 | 454.56 | 215.61 |
Tangible Book Value Per Share | 1.98 | 3.38 | 4.25 | 6.21 | 6.97 | 4.14 |